Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.
about
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaAdditive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling.Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro.miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in miceLiver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance.Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterolNASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis.Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis.Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects.Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death.c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus.Apoptotic pathways in adipose tissue.Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease.Saturated free fatty acids induce cholangiocyte lipoapoptosis.Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease.Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure.Caspase-2 deficiency enhances whole-body carbohydrate utilisation and prevents high-fat diet-induced obesity.Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death.Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis.Caspases in metabolic disease and their therapeutic potential.The effect of aging on mitochondrial and cytosolic hepatic intrinsic death pathway and apoptosis associated proteins in Fischer 344 rats.Apoptosis and non-alcoholic fatty liver diseases.
P2860
Q26767346-0D88E304-D955-441D-86BB-630206608528Q30620446-6FABE5D3-8A3E-4FAE-AAF5-644E1441CDF6Q33786900-4B695EE5-A282-4D6F-8758-A206060A44DCQ33815927-3445883A-9027-4478-A1B7-D14E0E4C1DCEQ34168368-9B086F57-EAAD-41C2-821B-DF13E30C731FQ34501819-7C0D93E3-8AD3-47E1-8736-0B36FB09D9B3Q35931190-D85BFA3D-66CE-422B-BA32-7EB7E2D67C47Q36333430-3F65B358-6659-48D8-90B7-41BAEC029436Q36477235-C44BDFDB-88C3-425D-945F-70802A482D63Q36588248-18CC51A0-BCFE-4FE8-9F1D-473EA87323D2Q36795583-A8098005-7CE9-4C1E-9004-5B24086FD420Q37643931-DB7360F3-966B-47B4-A3D4-DC398FD09900Q38028344-D249AA8B-3DED-4F78-BA1D-9427469FCF16Q38098902-528AB072-B18F-4702-877B-B5CEDE506C33Q38202220-F833BBE4-193B-4529-BB10-D86B906DA744Q39002205-620C12ED-EC1A-4AEB-B8D0-B45DB6D755AEQ39095568-0C98EC0E-8152-41D5-B7DD-0099388C65CCQ42123455-B42F7BF7-9C25-40EE-93AA-044F1CEE3451Q42517446-D1DB48A5-601D-45BC-9861-5A75AA0169E5Q43951595-E2DF8F54-4B90-4949-8CDD-A2ADFAF89C79Q47413881-0FC946BB-BB4A-4E6F-AF20-CE8B0D3457B2Q48242025-7678543D-B71C-4999-8FD5-02D0193E369EQ51225674-55CE8A93-6D24-4290-80A6-FEECD0603705Q53685192-C89893D8-B439-402D-812C-E3B7D27FB340Q55339592-820BC28F-EBA3-44C7-BE13-F4B90B623169Q55503094-1D385676-D665-4564-BD5D-A6746B3E116F
P2860
Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Apoptosis and insulin resistan ...... alcoholic fatty liver disease.
@en
Apoptosis and insulin resistan ...... alcoholic fatty liver disease.
@nl
type
label
Apoptosis and insulin resistan ...... alcoholic fatty liver disease.
@en
Apoptosis and insulin resistan ...... alcoholic fatty liver disease.
@nl
prefLabel
Apoptosis and insulin resistan ...... alcoholic fatty liver disease.
@en
Apoptosis and insulin resistan ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P1433
P1476
Apoptosis and insulin resistan ...... alcoholic fatty liver disease.
@en
P2093
A Silvestre
D M S Ferreira
H Cortez-Pinto
J Coutinho
M V Machado
T Evangelista
P2860
P2888
P304
P356
10.1007/S00125-011-2130-8
P577
2011-04-01T00:00:00Z